The STADA Group, a global manufacturer of high-quality generic drugs and consumer healthcare products, continues its growth trajectory in Europe. The company, headquartered in Germany, announced today that it is acquiring the pharmaceutical business of Biopharma, one of the key pharmaceutical producers in Ukraine.
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
GSK to receive upfront payment of approximately EUR301 million (£259m) and milestone payments for a total consideration of up to EUR955 million (£822m)
Acino and Takeda Pharmaceuticals announced today that they have signed an agreement for Acino to acquire parts of Takeda’s primary care portfolio in selected countries in the Middle East and Africa, and in Ukraine. The acquisition will further strengthen Acino’s position in these important regions.
Adicet Bio, Inc., a biopharmaceutical company focused on the development of allogeneic cell therapies for cancer using innovative gamma delta T cells, announced today the completion of an $80 million Series B financing.
The center, believed to be the first and largest of its kind, will use psychedelics to study the mind and identify therapies for diseases such as addiction, PTSD, and Alzheimer's
Zhejiang Jiuzhou Pharmaceutical Co. (603456.SH) on Thursday said it will acquire a unit of Novartis AG in eastern China for 790 million yuan (US$110.5 million).
Innovative Therapy Will Strengthen Amgen's Inflammation Portfolio for Patients Around the World Acquisition Expected to Accelerate Growth and Enhance Value for Amgen Shareholders
